TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | 4 | 4 | 13 | 17 | -6 | 63 | 16 |
| P | %wins | 75 | 50 | 75 | 50 | 50 | 50 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/17/12 12:10 | 12/14/12 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Jensen Peder | NC | D | P | 30 | 1.51 | 1 | 20 | 50 | 60 | D | -71 | -40 | -59 | -65 | -42 | 1 | 9 | 3 | 2 | 5 | 15 | -14 | 19 | 327 | |
6/5/12 19:38 | 6/5/12 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Jensen Peder | NC | D | P | 64 | 3.18 | 1 | 20 | 100 | 40 | D | -54 | -7 | 7 | -44 | -21 | -18 | -6 | -1 | 12 | 13 | 29 | 41 | -54 | -47 | |
11/18/11 14:52 | 11/18/11 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Jensen Peder | NC | D | P | 28 | 2.75 | 0 | 10 | 100 | 20 | D | -75 | -43 | -18 | 10 | 10 | -16 | -12 | -7 | 4 | -3 | -11 | 62 | 25 | -41 | |
5/16/11 18:01 | 5/12/11 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Jensen Peder | NC | D | P.d | 36 | 3.56 | 1 | 10 | New | 10 | D | 43 | -55 | -31 | -20 | -11 | -7 | -1 | -1 | -1 | -1 | 20 | -23 | -13 | 13 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |